Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04157036 · ClinicalTrials.gov registry record · Phase 3
Evaluation of Methylprednisolone or Ibuprofen on Efficacy of Nerve Blocks With Symptomatic Irreversible Pulpitis
A Phase 3 study, sponsored by Walter Reed National Military Medical Center.
- Terminated
- Registry status
- Phase 3
- Development phase
- 3
- Enrollment target
NCT04157036 is a Phase 3 study that was terminated before completion, run by Walter Reed National Military Medical Center. The registered enrollment target is 3 participants.
The verdict
NCT04157036, a Phase 3 study, was terminated before completion, sponsored by Walter Reed National Military Medical Center.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 3 participants
- Enrollment target
Study Summary
This prospective, randomized, double-blind study will compare the effect of oral premedication of ibuprofen and methylprednisolone on the anesthetic efficacy of an Inferior Alveolar Nerve Block (IANB) in adult patients with symptomatic irreversible pulpitis.
Interventions
- DRUG Ibuprofen
- DRUG Methylprednisolone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2020-02-01 |
| Est. Completion | 2021-10-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04157036
The ClinicalTrials.gov registry entry for NCT04157036 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Walter Reed National Military Medical Center, which has 48 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ibuprofen is the first listed.
NCT04157036 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04157036 about?
NCT04157036 is a clinical study titled "Evaluation of Methylprednisolone or Ibuprofen on Efficacy of Nerve Blocks With Symptomatic Irreversible Pulpitis". This prospective, randomized, double-blind study will compare the effect of oral premedication of ibuprofen and methylprednisolone on the anesthetic efficacy of an Inferior Alveolar Nerve Block (IANB) in adult patients with symptomatic irreversible pulpitis.
What is the current status of trial NCT04157036?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 3 participants. The study started on 2020-02-01. Estimated completion is 2021-10-06.
What interventions are being tested in trial NCT04157036?
The interventions under investigation include: Ibuprofen (DRUG), Methylprednisolone (DRUG).
Who is sponsoring clinical trial NCT04157036?
This trial is sponsored by Walter Reed National Military Medical Center, which has 48 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.